Work

2550 Phase Ib study of abiraterone acetate (AA) plus buparlisib (BKM120) or BEZ235 in patients (pts) with castration-resistant prostate cancer (CRPC)

Year: 2015

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(16)31369-7

Authors: K. Chi, D. Castellano, J. De Bono, G. Gravis, L. Dirix, J.P. Machiels, A. Mita, B. Mellado Gonzalez, C. Massard, L. Trandafir, D. Dey, D. Csonka, A. Chakravartty, K. Fizazi

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2512248932

FWCI: 0.264

Cites:

Cited by: 2

Related to: 10